Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 31 for “"MYH9"”.
-
The effects of mechanical strain on adhesion in Myh9-ablated podocytes
Myh9 is a gene that encodes for non-muscle myosin IIA (NM-IIA), an actin cytoskeleton component and protein involved in cell movement and adhesion in most cells, including podocytes. Autosomal dominant mutations in NM-IIA have been associated with focal segmental glomerular sclerosis (FSGS) in …
-
Studies on the influence of mutations in the Myh9 gene on platelet function
… contribute to the hemostatic defect found in MYH9-related disease patients. Therefore, a better understanding of the underlying biophysical mechanisms in thrombus formation and stabilization is warranted. This thesis demonstrates that an amino acid exchange at the positions 702, 1424 and 1841 …
-
T1alpha interacts with Myh9, a nonmuscle myosin, in type 1 lung epithelial cells
… T1α interacting protein candidates, most notably Myh9. Myh9 is a member of a family of non-muscle myosins which is expressed in the lung epithelium, as well as in the kidneys’ podocytes, where its absence leads to a phenotype similar to reduced expression of T1α. Moreover, we confirmed the …
-
New insights into the molecular regulation of kidney disease: contributions of APOL1 and MYH9
… the genes APOL1, encoding apolipoprotein L1, and MYH9, encoding non-muscle myosin heavy chain IIA (NMHCIIA). The mechanisms by which the disease-associated chromosome 22 haplotypes promote kidney damage are unknown. Apolipoprotein L1 is a circulating protein with no known role in kidney function. …
-
Myosin expression and podocyte function in kidney structure and function, in heterozygous MHY9 knockout mice
The gene Myh9 encodes non-muscle myosin heavy chain I lA, an essential podocyte cytoskeleton structural protein. Abnormalities in the MYH9 gene are associated with chronic kidney disease (common in people of African ancestry) and rare hereditary autosomal dominant syndromes. In the current study, …
-
Association of variants in APOL1, MYH9 and HMOX1 WITH micro-Albuminuria among Sickle Cell disease patients from Cameroon
… proteinuria and specific genetic variants in MYH9 and APOL1, and between estimated Glomerular Filtration Rate (eGFR) and End Stage Kidney Disease (ESKD) with HMOX1 variants among adult African Americans affected by SCD. However, the association between these variants and micro-albuminuria, a …
-
Mechanisms of LDL Transcytosis during Basal and Inflammatory States
… Using this method, myosin heavy chain 9 (MYH9) was identified. MYH9 was found to mediate exocytosis of LDL during transcytosis in vitro. In vivo, endothelial MYH9 was involved in accumulation of LDL within the aortic endothelium of mice and also contributed to atherogenesis without …
-
An Atat1/Mec-17-Myosin II axis controls ciliogenesis
… for cilium formation. In contrast, myosin IIA (Myh9) suppresses cilium formation. In Myh10 deficient cells, Myh9 inactivation significantly restores cilia formation. Myh10 antagonizes Myh9 and increases actin dynamics, permitting pericentrosomal preciliary complex formation required for cilium …
-
Characterization of Basal Endfeet Reveals Roles for Local Gene Regulation in Radial Glia and Cortical Development
… enriched in RGC basal endfeet, with MYH9 and MYH10 among the most abundant. Myh9 and Myh10 transcripts also localize to endfeet with distinct temporal dynamics. Although they each encode isoforms of non-muscle myosin II heavy chain, Myh9 and Myh10 have drastically different …
-
The Role of AKT Isoforms and Their Substrates in Metastatic Prostate Cancer
… experiment identified myosin heavy chain IIa (MYH9) as a novel direct substrate of AKT3 at serine 1943. Here, we validate the requirement of MYH9 for prostate cancer cell aggressiveness, as well as the requirement for activation at Ser1943 to mediate prostate cancer cell motility. Further, the …
-
Estudio de la asociación de los polimorfismos del gen MYH9 con la enfermedad renal crónica secundaria a nefroesclerosis hipertensiva, en una población del norte de España
… se ha asociado con polimorfismos del gen MYH9 en afroamericanos. El objetivo de nuestro trabajo es determinar si algún polimorfismo de dicho gen se relaciona en raza caucásica con la asociación de HTA esencial y nefroesclerosis, y conocer los marcadores clínicos de progresión a ERC …
-
Membrane Forces and Key Protein Determinants of Hematopoietic Cell Function: Lamins and Myosin-II in Hematopoiesis and CD47 in Immunotherapy of Cancer
… of MKs with mutations of the MIIA gene, MYH9, recapitulates MYH9–RD macrothrombocytopenia. Comparing MYH9–RD patient and normal donor platelets shows a similarity in pre/pro-platelets when normals are treated with blebbistatin. These findings provide evidence that regulation of MIIA …
-
Development of therapeutic strategies to identify novel drug targets of DLC1-deleted breast cancers
… with DLC1 deletion. I directly assessed MYH9, DNMT1 and the four members of the FBXW7-SCF complex, using siRNA-based SL assays. MYH9 inhibition resulted in a small but statistically significant decrease in cell numbers between the non-target (NT) control cell line and DLC1-HET. …
-
THE ROLE OF NON-MUSCLE MYOSIN IN TENDON AND ATTACHMENT UNIT FORMATION AND MATURATION
… of the predominant NM-II isoforms, NM-IIA (Myh9 gene) and NMII-B (Myh10 gene) affected both the formation and maturation of the attachment unit. In particular, the initial formation of the deltoid tuberosity (DT) attachment unit failed in limb mesenchyme lacking one copy of Myh9 and both …
-
Genetic Dissection and In Vivo Modeling of Sickle Cell Disease Nephropathy
… model systems. We demonstrated previously that MYH9 and APOL1, in linkage disequilibrium on chromosome 22, are strong, independent predictors of risk for proteinuria in SCD. This region, particularly two major risk variants (named G1 and G2) in APOL1, has been replicated widely in non-SCD …
-
Generation of Mouse Models of Human Hematopoietic Disease and their Use to Analyze Hematopoietic Development and Function
… and carried a missense mutation in Myh9 (Q1443L). The Myh97238/7238 mice are viable and have a more severe phenotype of macrothrombocytopenia. Myh97238 is the first mouse model for Myh9 related disorders that accurately models the genetic origins and the systemic manifestations of …
-
Anomalous diffusion of mRNA in the cytoplasm of HeLa cells
… individual RNA molecules expressing the MYH9 gene, they were labeled via MS2 stem loops bound to coat proteins tagged with the HaloTag-JF646 fluorophore. We then used single-particle tracking to obtain trajectories of individual molecules. Trajectories were analyzed in terms of their …
-
Susceptibility of perivenous macrophages to PRRSV and ASFV and search for PRRSV/ASFV entry mediators by the use of monoclonal antibodies
… the macrophage proteins Siglec1, ANXA1 and MYH9.
-
COMPREHENSIVE WHOLE GENOME SEQUENCING UNRAVELS THE COMPLEX GENOMIC LANDSCAPE OF NEUROBLASTOMA
… point mutations in 3 cancer-related genes, ESR1, MYH9 and SKI, the latter under-expressed in high-risk tumors. Focal and numerical copy number alterations associated with high and low risk tumors, respectively. Genomic rearrangement analysis revealed novel and recurrent translocations. Patients …
Page 1 of 2